ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $387,228 | -10.7% | 36,914 | +11.8% | 0.00% | – |
Q3 2023 | $433,791 | +62.2% | 33,013 | +55.5% | 0.00% | – |
Q2 2023 | $267,473 | -7.9% | 21,228 | -4.6% | 0.00% | – |
Q1 2023 | $290,480 | -72.9% | 22,259 | -63.4% | 0.00% | – |
Q4 2022 | $1,072,071 | -21.5% | 60,775 | -32.2% | 0.00% | -100.0% |
Q3 2022 | $1,366,000 | -38.2% | 89,695 | -39.8% | 0.00% | 0.0% |
Q2 2022 | $2,211,000 | +415.4% | 149,112 | +682.6% | 0.00% | – |
Q1 2022 | $429,000 | -18.4% | 19,053 | -33.2% | 0.00% | – |
Q4 2021 | $526,000 | -36.6% | 28,531 | -54.0% | 0.00% | – |
Q3 2021 | $829,000 | -75.8% | 61,967 | -66.6% | 0.00% | -100.0% |
Q2 2021 | $3,432,000 | +230.3% | 185,411 | +167.9% | 0.00% | – |
Q1 2021 | $1,039,000 | -24.3% | 69,203 | -27.2% | 0.00% | -100.0% |
Q4 2020 | $1,372,000 | +182.3% | 95,003 | +59.1% | 0.00% | – |
Q3 2020 | $486,000 | +7.0% | 59,694 | -11.0% | 0.00% | – |
Q2 2020 | $454,000 | +291.4% | 67,078 | +306.7% | 0.00% | – |
Q1 2020 | $116,000 | -74.2% | 16,493 | -63.9% | 0.00% | -100.0% |
Q4 2019 | $449,000 | +283.8% | 45,693 | +355.4% | 0.00% | – |
Q2 2019 | $117,000 | -14.0% | 10,034 | -29.8% | 0.00% | – |
Q1 2019 | $136,000 | -91.8% | 14,303 | -87.5% | 0.00% | -100.0% |
Q4 2017 | $1,660,000 | +93.5% | 114,068 | +89.3% | 0.01% | +66.7% |
Q3 2017 | $858,000 | +241.8% | 60,267 | +204.7% | 0.00% | +200.0% |
Q1 2017 | $251,000 | -69.4% | 19,782 | -75.3% | 0.00% | -75.0% |
Q4 2016 | $819,000 | +506.7% | 80,201 | +685.2% | 0.00% | +300.0% |
Q3 2016 | $135,000 | -83.4% | 10,214 | -84.0% | 0.00% | -75.0% |
Q2 2016 | $813,000 | +405.0% | 64,000 | +425.2% | 0.00% | +300.0% |
Q1 2016 | $161,000 | -90.4% | 12,185 | -88.9% | 0.00% | -90.0% |
Q4 2015 | $1,684,000 | +152.5% | 109,463 | +103.4% | 0.01% | +150.0% |
Q3 2015 | $667,000 | +353.7% | 53,810 | +401.4% | 0.00% | +300.0% |
Q2 2015 | $147,000 | -55.0% | 10,732 | -40.9% | 0.00% | -75.0% |
Q1 2014 | $327,000 | – | 18,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |